Generic fast-acting insulin is now legal because patents have expired. But generic insulin is still quite expensive in the US.
I sure do. I use Humalog now and it's out of patent. There just isn't a generic available for it because it's just not all that cost effective to do. Creating and producing a generic for biologics (like insulins) is not simple like it is for simple chemicals. As I understand it, they need to undergo trials and the like, which drastically raises the price of creating them.
There's also admelog, which is not a generic but is a "biosimilar" that is much cheaper.
But regardless, how does that change my argument?
Why is CA getting into generic insulin manufacturing when they could just have someone who knows what they are doing make it?
Why not just find an existing seller and negotiate some pricing deal and then subsidize it for people in CA?